PRESS RELEASE published on 05/12/2023 at 23:45, 2 years 10 months ago Relief Therapeutics Has Filed its 2022 Annual Report on Form 20-F with the U.S. Securities and Exchange Commission
PRESS RELEASE published on 05/03/2023 at 07:00, 2 years 10 months ago Relief Therapeutics Announces Implementation Timeline for Reverse Split of Ordinary Shares
PRESS RELEASE published on 05/01/2023 at 07:00, 2 years 10 months ago Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA™ Commercial Launch Progressing Ahead of Schedule
PRESS RELEASE published on 04/28/2023 at 19:00, 2 years 10 months ago Relief Therapeutics Announces Results of Extraordinary General Meeting of Shareholders
PRESS RELEASE published on 04/17/2023 at 07:00, 2 years 11 months ago Relief Therapeutics Announces Positive 12-Month Stability Data for Inhaled and Intravenous Preparations of RLF-100
PRESS RELEASE published on 04/14/2023 at 07:00, 2 years 11 months ago Relief Therapeutics Announces Full Year 2022 Financial Results and Provides Corporate Update
PRESS RELEASE published on 04/05/2023 at 07:00, 2 years 11 months ago Relief Therapeutics Announces Executive Leadership Team Change
PRESS RELEASE published on 04/04/2023 at 07:00, 2 years 11 months ago Relief Therapeutics Holding SA to Hold Extraordinary General Meeting of Shareholders
PRESS RELEASE published on 04/03/2023 at 07:00, 2 years 11 months ago Relief Therapeutics Appoints World-Renowned Gene Therapy Pioneer Guangping Gao, Ph.D. as Chair of Scientific Advisory Board
PRESS RELEASE published on 03/22/2023 at 07:00, 3 years ago Relief Therapeutics Announces Survey Results Identifying Preferred Urea Cycle Disorder Treatment Attributes Presented by Collaboration Partner at SIMD 2023
Published on 03/27/2026 at 15:35, 3 hours 14 minutes ago SouthGobi Announces Fourth Quarter and Full Year 2025 Financial and Operating Results
Published on 03/27/2026 at 12:30, 6 hours 19 minutes ago Pasinex Closes First Tranche of Over-Subscribed Non-Brokered Private Placement
Published on 03/27/2026 at 12:00, 6 hours 49 minutes ago Temas Appoints Scientific Advisory Board to Accelerate RCL Commercialisation and Global Development
Published on 03/27/2026 at 11:00, 7 hours 49 minutes ago RE Royalties Announces Strategic Review to Evaluate Path for Long-Term Value Creation
Published on 03/27/2026 at 18:25, 24 minutes ago Thieves Make a Break For It as 12 Tonnes of KITKAT Go Missing
Published on 03/27/2026 at 18:20, 29 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/27/2026 at 18:00, 49 minutes ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 28.02.26.
Published on 03/27/2026 at 17:47, 1 hour 2 minutes ago ROCTOOL: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 03/27/2026 at 18:40, 9 minutes ago 2026 share capital increase reserved for members of the Saint-Gobain Group employee savings plan
Published on 03/27/2026 at 18:40, 9 minutes ago Augmentation de capital 2026 réservée aux adhérents du Plan d’Epargne du Groupe Saint-Gobain
Published on 03/27/2026 at 17:53, 56 minutes ago Mise à disposition du Document d'enregistrement universel 2025 de Carrefour
Published on 03/27/2026 at 17:53, 56 minutes ago Publication of Carrefour's 2025 Universal Registration Document
Published on 03/27/2026 at 17:45, 1 hour 4 minutes ago MISE À DISPOSITION DU RAPPORT ANNUEL EXERCICE 2025
